This document discusses factors that affect enzyme activity such as temperature, pH, substrate and enzyme concentration. It also discusses extremophile enzymes (extremozymes) and how they are useful. Enzyme inhibition including competitive, noncompetitive and irreversible inhibition is explained. Examples of prescription drugs that inhibit enzymes like ACE inhibitors, sulfa drugs and penicillins are provided. Finally, the medical uses of enzymes in disease diagnosis, treatment and chemical analysis are briefly mentioned.
it's act as catalyst that increase the rate of chemical reaction.. it is used in many application area.... many enzymes are present in human body perform necessary function..
This power-point presentation will give a complete overview about enzymes, nomenclature of enzymes. Enzymes inhibition is also covered in this ppt. Along with some basin introduction to G- protein coupled receptors is also provided.
Catalysts are something that speeds up the chemical reaction. Almost all biochemical reactions require catalysts.
Enzymes are biocatalysts. Biochemical catalysts speed up the biochemical reactions.
In presence of an enzyme, less energy is required for the reaction to take place.
A catalyst may be defined as a substance that increases the velocity or rate of chemical reactions without itself undergoing any change in the overall process.
An artificial enzyme is a synthetic organic molecule or ion that mimics one or more functions of an enzyme.
Molecules are designed and modified to achieve some desirable features of enzymes.
Protein engineering has been developed to design and synthesize molecules with the attributes of enzymes for non-natural reactions.
They have a molecular weight of less than 2000 Dalton.
They have the ability to stabilize at a higher temperature.
They are also known as synzymes or enzyme mimics.
it's act as catalyst that increase the rate of chemical reaction.. it is used in many application area.... many enzymes are present in human body perform necessary function..
This power-point presentation will give a complete overview about enzymes, nomenclature of enzymes. Enzymes inhibition is also covered in this ppt. Along with some basin introduction to G- protein coupled receptors is also provided.
Catalysts are something that speeds up the chemical reaction. Almost all biochemical reactions require catalysts.
Enzymes are biocatalysts. Biochemical catalysts speed up the biochemical reactions.
In presence of an enzyme, less energy is required for the reaction to take place.
A catalyst may be defined as a substance that increases the velocity or rate of chemical reactions without itself undergoing any change in the overall process.
An artificial enzyme is a synthetic organic molecule or ion that mimics one or more functions of an enzyme.
Molecules are designed and modified to achieve some desirable features of enzymes.
Protein engineering has been developed to design and synthesize molecules with the attributes of enzymes for non-natural reactions.
They have a molecular weight of less than 2000 Dalton.
They have the ability to stabilize at a higher temperature.
They are also known as synzymes or enzyme mimics.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
1. Chapter 4- Enzymes and Vitamins
(Part B of Enzymes)
JEMIMAH JOY I. GUARIN
2. Part B:
• Factors that affect enzyme activity
• Extremozymes
• Enzyme Inhibition
• Prescription Drugs that Inhibit Enzyme Activity
• Medical Uses of Enzymes
3. Factors that Affect Enzyme Activity
Enzyme activity- is a measure of the rate at which an enzyme converts the
substrate to products in a biochemical reaction.
• Temperature
• pH
• Substrate concentration
• Enzyme concentration
4. Temperature
temperature molecules are moving faster and colliding more frequently.
temperature of an enzymatically catalyzed reaction;
the rate (velocity) of the reaction
5. Temperature
• Temperature increases beyond a certain point, and the increased energy begins to
cause disruptions in the tertiary structure of the enzyme enzyme denaturation.
• Change in tertiary structure at the active site impedes catalytic
action, and the enzyme activity quickly decreases as the
temperature climbs past this point.
• Optimum temperature- is the temperature at which an enzyme
exhibits maximum activity.
6. Temperature
Example:
Human enzymes the optimum temperature is 37°C.
-If it exceeds 40°C, it can be a life-threatening situation because such a
temperature is sufficient to initiate enzyme denaturation.
Autoclaves- a high temperature, high-pressure vessels
Wherein super-heated stem is used to produce a
Temperature is sufficient to denature bacterial enzymes.
7. pH
• The pH of an enzyme’s environment can affect its activity.
• Small changes in pH can result in enzyme denaturation and subsequent loss of
catalytic activity.
• Most enzymes exhibit maximum activity over a very narrow pH range.
• Optimum pH- is the pH at which an enzyme exhibits maximum activity.
• Biochemical buffers help maintain the optimum pH for an enzyme.
• Enzyme physiological pH range: 7.0-7.5
• Exception: the digestive enzymes pepsin=2.0 ; trypsin=8.0
• A variation from normal pH can also affect substrates, causing either
Protonation or deprotonation of groups on the substrate.
8. Substrate Concentration
• Saturation curve- is when the concentration
of an enzyme is kept constant and the
concentration of substrate is increased.
• Each substrate must occupy an enzyme
active site for a finite amount of time, and
the products must leave the site before the
cycle can be repeated.
• Turnover number- is the number of substrate
molecules transformed per minute by one
molecule of enzyme under optimum
conditions of temperature, pH, and
saturation.
9. Enzyme Concentration
• The concentration of substrate in a reaction is much
higher than that of the enzyme.
• The greater the enzyme concentration, the greater
the reaction rate.
10.
11. Extremozymes
• Extremophile
- is a microorganism that thrives in extreme environments,
environments in which humans and most other forms of life could not
survive.
-comes from the Latin words: extremus extreme; philia love
• The ability of extremophiles to survive under such harsh conditions is
related to the amino acid sequences present in the enzymes
(proteins) of extremophiles.
12. Extremozymes
Types of Extremophiles:
Acidophiles- optimal growth at pH levels of 3.0 or below.
Alkaliphiles- optimal growth at pH levels of 9.0 or above.
Halophiles- high salinity, a salinity that exceeds 0.2 M NaCl needed for growth.
Hyperthermophiles- a temperature between 80°C and 121°C needed to thrive.
Piezophiles- a high hydrostatic pressure needed for growth.
Xerophiles- extremely dry conditions needed for growth.
Cryophiles- a temperature of 15°C or lower needed for growth.
13. Extremozymes
-is a microbial enzyme active at conditions that would inactivate human enzymes
as well as enzymes present in other types of higher organisms.
14. Extremozymes
General approach in the development of commercially useful enzymes using
extremophile sources:
1. Samples containing the extremophile are gathered from the extreme
environment where it is found.
2. DNA material is extracted from the extremophile and processed.
3. Macroscopic amounts of the DNA are produced using the polymerase chain
reaction.
4. The macroscopic amount of DNA is analyzed to identify the genes present that
are involved in extremozyme production.
5. Genetic engineering techniques are used to insert the extremozyme gene into
bacteria, which then produce the extremozyme.
6. The process is then commercialized.
15. Enzyme Inhibition
Enzyme inhibitor- is a substance that slows or stops the normal catalytic function of
an enzyme by binding to it.
-Reversible competitive inhibition
-Reversible noncompetitive inhibition
-Irreversible inhibition
16. Reversible Competitive Inhibition
Competitive enzyme inhibitor
-is a molecule that sufficiently resembles an enzyme-substrate in shape and
charge distribution that it can compete with the substrate for occupancy of the
enzyme’s active site.
-It decreases enzyme activity.
17. Reversible Competitive Inhibition
-It is a reversible process because it is maintained by weak interactions (hydrogen
bonds, etc.).
-Competitive inhibition can be reduced by simply increasing the concentration of
the substrate.
Within a
fraction of a
second, the
complex
breaks up.
The empty
active site is
then for a
navailableew
occupant.
Substrate and
inhibitor again
compete for
the empty
active site.
20. Reversible Noncompetitive Inhibition
-Lowering the concentration of a noncompetitive inhibitor sufficiently does free up
many enzymes, which then return to normal activity.
Examples:
Heavy metal ions: 𝑃𝑃𝑃𝑃 2+
, 𝐴𝐴𝐴𝐴+
, 𝐻𝐻𝐻𝐻2+
-the binding site for these ions are sulfhydryl groups (-SH) located away from
the active site.
-Metal sulfide linkages are formed, an effect that disrupts the 2nd and tertiary
structure.
21. Irreversible Inhibition
Irreversible enzyme inhibitor
-is a molecule that inactivates enzymes by forming a strong covalent bond
to an amino acid side-chain group at the enzyme’s active site.
-do not have structures similar to the enzyme’s normal substrate.
-The inhibitor-active site is sufficiently strong.
-Enzyme is permanently deactivated.
Example:
The actions of chemical warfare agents (nerve gases) and organophosphate
insecticides.
22.
23. Prescription Drugs that Inhibit Enzyme
Activity
• ACE Inhibitors- used to treat high blood pressure conditions as well as several
heart conditions
• Two well-known families of antibiotics:
Sulfa drugs
Penicillins
24. ACE Inhibitors
• Angiotensin-converting enzyme
• Angiotensin is an octapeptide hormone involved in blood pressure regulation.
• Angiotensin inactive form zymogen angiotensinogen
• ACE converts the inactive decapeptide zymogen to the active octapeptide form
(angiotensin) by cleaving 2 amino acids from the zymogen structure.
25. ACE Inhibitors
• This medications block the action of ACE in converting angiotensinogen to
angiotensin.
• The effect of this is a lower blood pressure.
• Lisinopril- heavily prescribed for treatment of moderately elevated blood pressure
conditions.
-1-carboxy-3-phenylpropyl derivative of the dipeptide Lys-Pro.
26. Sulfa Drugs
• Antibacterial activity of sulfanilamide Gerhard Domagk in 1932.
• The first antibiotics in the medical field.
• Antibiotic- is a substance that kills bacteria or inhibits their growth.
-they inhibit specific enzymes essential to the life processes of the bacteria.
Example:
Sulfanilamide inhibits bacterial growth because it is structurally similar to PABA
(p-aminobenzoic acid).
28. Penicillins
• One of the most widely used antibiotics.
• Accidentally discovered by Alexander Fleming in 1928.
29. Penicillins
• It inhibits transpeptidase.
-an enzyme that catalyzes the formation of peptide cross-links
between polysaccharide strands in bacterial cell walls.
• Its unique action depends on 2 aspects of enzyme deactivation:
-structural similarity to the enzyme’s natural substrate
-irreversible inhibition
• Is highly specific in binding to the active site of transpeptidase.
• Acts as a very selective competitive inhibitor.
30. Penicillins
• Penicillin does not usually interfere with normal metabolism in humans because of
its highly selective binding to bacterial transpeptidase.
• Penicillin an extremely useful antibiotic.
31. Medical Uses of Enzymes
• Enzymes can be used to diagnose certain diseases.
example: Enzyme concentrations can be useful in obtaining information
about a heart attack (blood enzyme).
32. Medical Uses of Enzymes
• Enzymes can be used in the treatment of diseases.
example: Tissue plasminogen activator (TPA)
• Enzymes used for chemical analysis in the clinical laboratory.
example: Blood urea nitrogen test (BUN)